News

New Digital Europe calls open for submission

Published on | 1 year ago

Programmes Digital Europe AI Continent Cybersecurity Advanced Digital Skills Deployment: Best use of technologies Semiconductors

A new round of calls within the Digital Europe programme have been opened for submission today.

These are the new opportunities within 5 Specific Objectives ((SOs) - Specific Objectives are sub-domains of the Digital Europe programme):

SO 2 - AI, data & cloud

SO 3 - Cybersecurity

SO 4 - Advanced Digital Skills

SO 5 - Deployment & best use of digital technologies

SO 6 - Semiconductors

More information on these calls (SOs 2, 3, 4, and 5) can also be found in the recording of our NCP Flanders info session.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1772 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.